Both of the results yielded a decreased risk for statin-related ADRs among −388G allele carriers, although the pooled effect estimates did not reach statistical significance (AG/GG vs.
← all excerpts
Association between SLCO1B1 -521T>C and -388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis.
1
—
—